Pt. Prodia Stem Cell Indonesia
Clinical trials sponsored by Pt. Prodia Stem Cell Indonesia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could stem cells be the key to saving lives from Sepsis-Induced lung failure? Results expected Dec 2026 (estimated)
- Can stem cells repair a scarred liver? new trial hopes so Results expected Jun 2027 (estimated)
- Stem cell therapy for rare eye disease passes 5-year safety check Results expected Jul 2027 (estimated)
- Stem cell injection aims to repair kidneys in diabetes patients Results expected Jul 2027 (estimated)
- Could stem cells save sight? new trial tests umbilical cord therapy for eye disease Results expected Jul 2027 (estimated)
-
Stem cell therapy for rare eye disease passes 5-year safety check
Disease control Not yet recruitingThis study follows up 18 people who received umbilical cord stem cells or conditioned medium for retinitis pigmentosa, a rare eye disease that causes vision loss. Researchers will check vision, eye structure, and safety five years after the injection. The goal is to see if the tr…
Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could stem cells save sight? new trial tests umbilical cord therapy for eye disease
Disease control Not yet recruitingThis study tests whether stem cells from umbilical cord tissue can safely slow vision loss in people with retinitis pigmentosa, an inherited eye disease. Thirty participants will receive one of two doses injected around the eye and be monitored for six months. The main goals are …
Phase 2/3 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC